These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9477644

  • 21. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
    Horng SG, Wang TH, Wang HS.
    Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
    [Abstract] [Full Text] [Related]

  • 22. Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome.
    Yasmin E, Glanville J, Barth J, Balen AH.
    Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):67-71. PubMed ID: 21277073
    [Abstract] [Full Text] [Related]

  • 23. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D.
    Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
    [Abstract] [Full Text] [Related]

  • 24. The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS).
    Wassell J, Michail M, Soliman N, Wardle PG.
    Clin Lab; 2011 Jan; 57(1-2):95-8. PubMed ID: 21391472
    [Abstract] [Full Text] [Related]

  • 25. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB, Bagis T, Zeyneloglu HB, Tarim E, Aslan E, Haydardedeoglu B, Erkanli S.
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [Abstract] [Full Text] [Related]

  • 26. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K, Hampl R, Nĕmcová D, Hill M, Hoza J, Kot'átková A, Stárka L, Vrbíková J, Zamrazil V.
    Cas Lek Cesk; 2002 Feb 15; 141(3):89-95. PubMed ID: 11925670
    [Abstract] [Full Text] [Related]

  • 27. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
    Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M, Skrha J, Zivny J, Skrenkova J.
    Hum Reprod; 2005 Jan 15; 20(1):180-4. PubMed ID: 15576394
    [Abstract] [Full Text] [Related]

  • 28. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 15; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 29. Effect of metformin on IGF-1 and IGFBP-1 levels in obese patients with polycystic ovary syndrome.
    Seibel SA, Chou KH, Capp E, Spritzer PM, von Eye Corleta H.
    Eur J Obstet Gynecol Reprod Biol; 2008 May 15; 138(1):122-4. PubMed ID: 17350746
    [No Abstract] [Full Text] [Related]

  • 30. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
    Nawrocka J, Starczewski A.
    Gynecol Endocrinol; 2007 Apr 15; 23(4):231-7. PubMed ID: 17505944
    [Abstract] [Full Text] [Related]

  • 31. [Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].
    Wang A, Li M, Lu C.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Dec 15; 33(12):731-4. PubMed ID: 10806662
    [Abstract] [Full Text] [Related]

  • 32. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A.
    J Endocrinol; 2005 Jan 15; 184(1):233-9. PubMed ID: 15642799
    [Abstract] [Full Text] [Related]

  • 33. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan 15; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 34. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 15; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 35. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
    Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM.
    Hum Reprod; 2006 Jan 15; 21(1):109-20. PubMed ID: 16155076
    [Abstract] [Full Text] [Related]

  • 36. Does metformin induce ovulation in normoandrogenic anovulatory women?
    Carmina E, Lobo RA.
    Am J Obstet Gynecol; 2004 Nov 15; 191(5):1580-4. PubMed ID: 15547527
    [Abstract] [Full Text] [Related]

  • 37. Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone.
    Sander V, Luchetti CG, Solano ME, Elia E, Di Girolamo G, Gonzalez C, Motta AB.
    Reproduction; 2006 Mar 15; 131(3):591-602. PubMed ID: 16514202
    [Abstract] [Full Text] [Related]

  • 38. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.
    Diabetes; 2008 Jun 15; 57(6):1501-7. PubMed ID: 18375437
    [Abstract] [Full Text] [Related]

  • 39. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 15; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 40. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
    Abd El Aal DE, Mohamed SA, Amine AF, Meki AR.
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb 01; 118(2):219-24. PubMed ID: 15653207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.